Relation between uric acid in blood and in saliva of patients with high BP recordings in pregnancy and in normal pregnancy.
Phase 2
- Conditions
- Health Condition 1: O140- Mild to moderate pre-eclampsia
- Registration Number
- CTRI/2020/12/029693
- Lead Sponsor
- Kasturba Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
pregnant women with or without pre-eclampsia at the gestation of 20 weeks and above
Exclusion Criteria
multiple pregnancy, diabetes mellitus, chronic
hypertension, any other cardiovascular disease, gout, connective tissue
disorder, renal or liver disease, history of thromboembolism, history of any
chronic illness, neural tube defect and other congenital malformation, patients
with oral infection, poor oral hygiene and recent oral injuries, Maternal or fetal
indication for iatrogenic preterm delivery
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess if there is correlation between serum and salivary uric acid with each other and with pre-eclampsia and to assess their relation with neonatal outcome.Timepoint: Salivary uric acid and serum uric acid once at the time of diagnosis of pre-eclampsia ( 20weeks gestation or above) <br/ ><br> <br/ ><br>Neonatal outcome at delivery
- Secondary Outcome Measures
Name Time Method If salivary uric acid can be used as a non invasive spot test for predicting pre-eclampsia in pregnant women.Timepoint: Salivary and serum uric acid at the time of diagnosis of pre-eclampsia (20 weeks of gestation or more) <br/ ><br> <br/ ><br>Neonatal outcome at time of delivery